NASDAQ:XFOR
X4 Pharmaceuticals
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.x4pharma.comipo date
Nov 16, 2017
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the ch...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus